Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-258589
Filing Date
2024-11-14
Accepted
2024-11-14 16:15:56
Documents
2
Group Members
KHOSLA VENTURES ASSOCIATES VI, LLCKHOSLA VENTURES OPPORTUNITY ASSOCIATES I, LLCKHOSLA VENTURES OPPORTUNITY I, LPVINOD KHOSLAVK SERVICES, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d871469dsc13g.htm SC 13G 127150
2 EX-99.1 d871469dex991.htm EX-99.1 6717
  Complete submission text file 0001193125-24-258589.txt   135602
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Subject) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94634 | Film No.: 241462566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650.376.8526
Khosla Ventures VI, L.P. (Filed by) CIK: 0001734961 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G